INSIGHTS ON PHARMACEUTICAL INSPECTION
-
The Role Of IV Bag Inspection In Drug Manufacturing
Advanced IV bag inspection technologies ensure patient safety and regulatory compliance in drug manufacturing. Learn more about automated leak detection and quality control innovations to optimize your business.
-
Microbial Challenge In-Use Studies
Learn more about how a partner with expertise can help you navigate the complex landscape of microbial challenge in-use studies and ensure the highest standards of patient care.
-
5 Common Bowie-Dick Test Failures And How To Prevent Them
Bowie-Dick test failures indicate serious sterilization issues. Learn the five most common causes and proven strategies to prevent downtime, compliance risks, and compromised product integrity.
-
Supporting GLP-1 And Peptides With Integrated Solutions
Accelerate GLP-1 and peptide therapy development with integrated drug containment, delivery, machinery, and analytics for reliable combination product performance.
-
A Holistic Approach To CCI Is A Deterministic Approach1/30/2026
A modern approach to CCI blends smart design, risk‑based strategies, and deterministic testing to safeguard sterile products. Learn how lifecycle thinking and practical sampling plans strengthen quality.
-
A Practical Packaging Components Checklist For Emerging Biotechs6/20/2024
A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.
-
Cryogenic Storage Of IV Bags For Cell And Gene Therapies12/18/2025
Cryogenic storage can compromise packaging integrity for cell and gene therapies. Learn how vacuum decay technology detects micro leaks and ensures product safety under extreme conditions.
-
ICP-MS And ICP-OES: Tools For Elemental Impurity Analysis12/11/2024
Leverage advanced elemental impurity testing methods to ensure the safety, compliance, and accuracy of your drug products throughout the manufacturing process.
-
Ensure Quality Control With Innovative Software7/1/2025
Ensure unmatched product quality with an X-ray system paired with an innovative software that detects contaminants and missing items in stacked packaged goods with precision.
PHARMACEUTICAL INSPECTION SOLUTIONS
-
The VeriPac 410 inspection system uses force decay technology for non-destructive seal and leak detection for blister packs, sachets, and pouches with low headspace.
-
The XR75 Pharma X-ray is optimized for the quality control of pharmaceutical, nutraceutical, and cosmetic products in thin opaque packaging materials that cannot be inspected manually or with visual systems. The leakage prevention curtains are designed to leave a 10 mm-clearance that ensures safety and reduces false rejects caused by product jams or changed orientation during conveyance. The system checks for different product integrity issues simultaneously: products trapped in seals, missing, chipped, or broken tablets in blisters, and the presence of foreign contaminants. The high-resolution X-ray images ensure reliable inspection of the small items at belt speed up to 90 m/min.
-
The VeriPac 425 offers container closure integrity testing of diagnostic test cassettes in flexible packaging. Test cycles are rapid and provide pass/fail results as well as supporting quantitative result data.
-
This checkweigher ensures stable transfer and high-accuracy measurement of small containers that can easily topple during conveyance, such as eye lotion bottles, nasal drop vials, and cosmetics containers. The model features a conveyor with three integrated side-grip belts that keep products upright throughout the infeed, weigh table, and outfeed sections. The width of these side-grip belts is easily adjustable to accommodate different product sizes, with a standard range of 20-40 mm and an optional maximum width extension up to 100 mm. This design allows for a processing speed of up to 200 bottles per minute and an accuracy of +/- 0.02 g. The rejector uses a gate-type mechanism, with an optional air jet rejector for products up to 200 g. The system is compliant with federal regulation 21 CFR Part 11 for the integrity of electronic records and signatures, with features such as password authentication, audit trail of operation data, and encryption/decryption of exported data.
-
As part of Stevanato Group’s commitment to R&D, our analytical testing facilities focus on investigating physico-chemical properties of primary packaging materials and components and studying the interactions between container closure system and drugs. Stevanato Group relies on a multi-disciplinary team of highly skilled professionals, including, scientists, engineers, pharmaceutical chemists and biotechnologists. Their knowledge and experience covers a range of specialized areas including container closure systems and drug-delivery devices.